ATA408875A - Verfahren zur herstellung von chinazolin-derivaten - Google Patents
Verfahren zur herstellung von chinazolin-derivatenInfo
- Publication number
- ATA408875A ATA408875A AT408875A AT408875A ATA408875A AT A408875 A ATA408875 A AT A408875A AT 408875 A AT408875 A AT 408875A AT 408875 A AT408875 A AT 408875A AT A408875 A ATA408875 A AT A408875A
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- quinazoline derivatives
- quinazoline
- derivatives
- Prior art date
Links
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical class N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49061684A JPS5919098B2 (ja) | 1974-05-30 | 1974-05-30 | キナゾリン誘導体の製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA408875A true ATA408875A (de) | 1978-03-15 |
| AT346335B AT346335B (de) | 1978-11-10 |
Family
ID=13178325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT408875A AT346335B (de) | 1974-05-30 | 1975-05-28 | Verfahren zur herstellung von chinazolin- derivaten |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS5919098B2 (de) |
| AT (1) | AT346335B (de) |
| CA (1) | CA1047967A (de) |
| CH (1) | CH599172A5 (de) |
| NL (1) | NL7506338A (de) |
| SE (1) | SE414403B (de) |
-
1974
- 1974-05-30 JP JP49061684A patent/JPS5919098B2/ja not_active Expired
-
1975
- 1975-05-28 AT AT408875A patent/AT346335B/de not_active IP Right Cessation
- 1975-05-29 CA CA228,044A patent/CA1047967A/en not_active Expired
- 1975-05-29 SE SE7506140A patent/SE414403B/sv unknown
- 1975-05-29 NL NL7506338A patent/NL7506338A/xx not_active Application Discontinuation
- 1975-05-30 CH CH702675A patent/CH599172A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE7506140L (sv) | 1975-12-01 |
| CH599172A5 (en) | 1978-05-12 |
| AT346335B (de) | 1978-11-10 |
| CA1047967A (en) | 1979-02-06 |
| SE414403B (sv) | 1980-07-28 |
| NL7506338A (nl) | 1975-12-02 |
| JPS50151887A (de) | 1975-12-06 |
| JPS5919098B2 (ja) | 1984-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD129648A5 (de) | Verfahren zur herstellung von prostaglandinderivaten | |
| DD127731A5 (de) | Verfahren zur herstellung von cephalosporansaeurederivaten | |
| ATA966275A (de) | Verfahren zur herstellung von p-benzochinondiketalen | |
| AT343802B (de) | Verfahren zur herstellung von derivaten von 4,6-di-0- (aminoglycosyl)-2-deoxystreptaminen | |
| AT333774B (de) | Verfahren zur herstellung von 3-phenylpyridazonen | |
| AT344154B (de) | Verfahren zur herstellung von 5-fluor-2-methyl-1- (p-methylsulfinylbenzyliden)-indenyl-3-essigsaeure | |
| AT342602B (de) | Verfahren zur herstellung von 1-substituierten 2-methyl-tetrahydropyrimidinen | |
| AT338244B (de) | Verfahren zur herstellung von 2-nitrobenzaldehyd | |
| AT333749B (de) | Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten | |
| DD122962A5 (de) | Verfahren zur herstellung von halogenanthrachinonen | |
| AT343120B (de) | Verfahren zur herstellung von 6-chlor-2-chlormethyl-4-phenylchinazolin-3-oxid | |
| AT341672B (de) | Verfahren zur herstellung von 3-methylencephamsulfoxiden | |
| AT334909B (de) | Verfahren zur herstellung von substituierten thiocarbaminsaure-s-alkylestern | |
| AT338243B (de) | Verfahren zur herstellung von 2-nitrobenzaldehyd | |
| AT339279B (de) | Verfahren zur herstellung von 5-sulfamoylanthranilsauren | |
| AT344675B (de) | Verfahren zur herstellung von 3-fluor-dl-alanin | |
| DD122986A1 (de) | Verfahren zur herstellung von polyesteralkoholen | |
| AT343668B (de) | Verfahren zur herstellung von benzoguanamin-derivaten | |
| AT350199B (de) | Verfahren zur herstellung von 17-monoestern von 17alfa,21-dihydroxysteroiden | |
| AT335063B (de) | Verfahren zur herstellung von d(-)-alfa-amino-p-hydroxybenzylpenicillin | |
| DD122973A5 (de) | Verfahren zur herstellung von 4a-aryl-transdecahydroisochinolinen | |
| AT347469B (de) | Verfahren zur herstellung von benzodiazepin- derivaten | |
| ATA408875A (de) | Verfahren zur herstellung von chinazolin-derivaten | |
| DD128735A5 (de) | Verfahren zur herstellung von 3-cyanopenamen | |
| ATA517075A (de) | Verfahren zur herstellung von neuen 3- acylamino-2-azetidinonderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| ELJ | Ceased due to non-payment of the annual fee |